Compare Heima (HEI) vs Injective (INJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heima vs Injective — how do they compare? Heima trades at Rp2,488 (market cap Rp194,41M, Rp320,82M 24h volume), while Injective trades at Rp78,615 (market cap Rp7,83T, Rp673,83M 24h volume). The key difference: Injective is far larger — about 40275.7× Heima's market cap, and Heima's supply is capped (81,5M / 100M HEI (82%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Heima for 11 Days and Injective for 37 Days on average.
| HEI | INJ | |
|---|---|---|
Market Cap | Rp194,41M | Rp7,83T |
Volume (24h) | Rp320,82M | Rp673,83M |
Circulating Supply | 81,5M / 100M HEI (82%) | 100M INJ |
Typical Hold Time | 11 Days | 37 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HEI (Heima) is currently trading at Rp2,198.904 with a market cap of Rp179.25 million, showing bullish technical signals despite mixed moving averages. The token has a circulating supply of 81.5 million HEI (82% of max supply) with an average hold time of 11 days. Technical indicators show strong momentum with RSI_6 at 21.06 (oversold) and ADX readings above 66 indicating strong trend strength. Support levels are established at Rp1,831 (S3) to Rp2,087 (S1), with resistance at Rp2,343 (R1) to Rp2,600 (R3).
Overall outlook is cautiously optimistic with bullish oscillators supporting upward momentum, though bearish moving averages suggest near-term consolidation. Key opportunities include potential breakout above Rp2,241 pivot point, while risks include low liquidity and typical crypto volatility. Investors should monitor volume patterns and network adoption metrics for confirmation of sustained momentum.
INJ is currently trading at Rp81,847 with a market cap of Rp8.18 trillion, showing bearish technical signals with moving averages indicating selling pressure while oscillators remain neutral. The token faces immediate resistance at Rp82,576 with support at Rp81,456. Recent on-chain data shows an average hold time of 37 days, suggesting moderate holding patterns among investors.
Overall outlook remains cautious with technical indicators favoring bearish momentum. Key opportunities include potential bounce from support levels, while major risks involve continued selling pressure and crypto market volatility. Investors should monitor network adoption metrics and exchange liquidity closely.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Heima
As an evolution of the Litentry Network, the Heima Network was developed focusing on decentralized identity and privacy solutions. Building on this foundation, Heima expanded its scope to address cross-chain asset management and multi-chain interoperability.
Read more on HEI →About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →
